Tech Tuesday: Brain cancer vaccines
Dr. Elias Sayour was featured for UF Innovate’s Tech Tuesday, discussing his work to develop mRNA brain cancer vaccines.
Dr. Elias Sayour was featured for UF Innovate’s Tech Tuesday, discussing his work to develop mRNA brain cancer vaccines.
Dr. Christina von Roemeling and colleagues have developed a novel strategy to deliver genetic material directly to cells associated with glioblastoma.
First-ever human clinical trials of new experimental treatments for Group 4 medulloblastoma to begin at UF this fall.
Dr. David Borchelt (Lifetime Achievement Award, pictured below) and Dr. Maryam Rahman (collegewide Clinical Excellence Award) among awardees.
See media highlights stemming from May 9 paper published in the journal Cell.
In The Conversation Drs. John Ligon and Christina von Roemeling discuss new paper they co-authored in the journal Cell.
UF-developed mRNA vaccine quickly reprogrammed the immune system to attack glioblastoma.
In The Conversation, Dr. Giridhar Kalamangalam tells the story of the game-changing medical test that measures brain electrical activity.
Learn about Dr. Maryam Rahman's impact in the OR and the lab.
Dr. Maryam Rahman has been awarded a $738K grant for preclinical testing of a novel cancer vaccine to treat malignant brain tumors.